The rise of healthcare startups has affected both the number of entrepreneurs and investors present in the sector: during the first 9 months of 2020, investment in Catalan startups in the health sector exceeded 120 million euros.
In today's article, we discover 11 innovative projects focused on the health sector, which are revolutionizing the Spanish market:
Sycai is an Artificial Intelligence (AI) software development company specialized in the application of Deep Learning to medical image interpretation. The company is working on the development of a product capable of making an early and non-invasive diagnosis of any abdominal cancer. Specifically, Sycai Medical is a tool capable of detecting, characterizing and classifying lesions in the 5 existing pancreatic lesion subtypes, with up to 90% accuracy.
Aether Tech works with the mission of developing disruptive technologies for the treatment of patients with chronic diseases. The company is working on the development of Emily, a solution based on Artificial Intelligence and Edge computing technologies for the automatic and personalized regulation of the flow of oxygen supplied to patients with respiratory diseases, together with a Big Data platform and monitoring and monitoring apps.
Innitius has developed Fine Birth, a device based on pure Torsion Waves, capable of diagnosing in real time the risk of premature birth and the chances of successful labor induction. The solution helps to manage real spontaneous preterm births more effectively and reduce their sequelae in newborns. In addition, Fine Birth is a portable and independent device, specifically designed to be applied at the point of care of pregnant women.
Neobit Pharma has been working, for more than 15 years, in the pharmaceutical industry. The team develops state-of-the-art nutraceuticals, with natural and mineral components of the highest quality, used successfully in the creation of natural therapies. Currently, Neobit pharma customers can benefit from: Fortabit to strengthen the immune system, Colesbit to regulate cholesterol levels and Serenbit to calm anxiety and stress.
Insulclock works to improve the quality of life and adherence to treatment in insulin-dependent patients, a condition that affects approximately 1 in 10 diabetic patients in Spain. The Insulclock team has developed an electronic device, capable of adapting to all types of insulin pens, which communicates directly via the APP with smartphones and other gadgets and reports exactly when and how much medication has been administered. In addition, patients have the option of including alarms and reminders for insulin administration.
Onira Research focuses its activity on the development of solutions for the diagnosis and subsequent treatment of sleep. Hiparco, the company's first product, consisting of an in-vitro diagnostic kit, is able to determine, through an effective, predictive and scalable algorithm, if a patient with Resistant Hypertension could be treated using a CPAP device, originally indicated for the treatment of obstructive sleep apnea.
Idoven combines Artificial Intelligence algorithms in the cloud with wearable technology to detect early cardiac problems (such as alterations in cardiac electrical activity and arrhythmias) and achieve diseases such as myocardial infarction and sudden death through the analysis of long-term electrocardiograms. To do this, the user must monitor their heart for days or weeks with a non-invasive device.
Qrem Cytokine has the mission of: “To lead the implementation of autologous regenerative therapies using Lab-in-a-Box devices that allow these therapies to be offered to as many people as possible at a competitive cost”. The team has developed a system, consisting of a machine and a kit, for the treatment of osteoarthritis. From the patient's blood, a serum rich in cytokines is obtained, which manages to slow the progression of the disease through its subsequent infiltration into the joint itself.
Iomed uses Natural Language Processing (PLN) to transform Electronic Health Records (EHR) into structured RWD, thus optimizing the management of clinical data. Through MEL, Iomed's software, hospitals can host a large number of clinical variables in a single database, with anonymized patients, thus reducing the time spent recruiting patients and, in turn, accelerating clinical research.
New Born Solutions develops solutions for the early detection of particles in surface fluids of the body, quickly, easily and economically. The solution uses high-resolution ultrasound technologies, allowing infections to be detected at very superficial levels. The team has developed Neosonics, the first non-invasive device for the detection of meningitis in infants.
ICU Medical Technologies works for the commercialization of KronoSafe, a temporary cardiac stimulation system with active attachment electrodes. The solution is specifically focused on reducing the high rate of complications that occur during temporary cardiac stimulation procedures. For now, the effectiveness of the device has been tested in a clinical study with 20 patients, reducing the length of stay in the ICU by 85%.
